Detalhe da pesquisa
1.
Low B-cell content is associated with a CD73-low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma.
Br J Haematol
; 201(6): 1097-1102, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921595
2.
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Br J Haematol
; 196(3): 606-616, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775591
3.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(2): 223-234, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539742
4.
Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP.
Haematologica
; 106(6): 1684-1692, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381573
5.
Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group.
Blood
; 132(14): 1519-1525, 2018 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064977
6.
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
Br J Haematol
; 185(1): 42-52, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30592027
7.
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma.
Am J Hematol
; 94(11): 1208-1213, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396979
8.
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
Lancet Oncol
; 18(12): 1680-1687, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133014
9.
Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.
Hematol Oncol
; 40(4): 801-804, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313381
10.
PET-guided omission of radiotherapy in Hodgkin lymphoma - Authors' reply.
Lancet Oncol
; 22(5): e182, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33932379
11.
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
Br J Haematol
; 171(4): 547-56, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26310520
12.
Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma.
Blood
; 121(17): 3431-3, 2013 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23444403
13.
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Blood
; 122(26): 4246-52; quiz 4292, 2013 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24100447
14.
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).
Br J Haematol
; 167(2): 238-42, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965443
15.
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
N Engl J Med
; 363(7): 640-52, 2010 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20818855
16.
Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma.
Am J Hematol
; 88(2): 113-5, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225085
17.
AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial.
Leuk Lymphoma
; 63(8): 1871-1878, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848865
18.
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
Lancet Haematol
; 8(4): e278-e288, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770483
19.
Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group.
J Clin Oncol
; 38(7): 698-705, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626571
20.
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
J Clin Oncol
; 36(25): 2603-2611, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29989855